US Broker Ratings

The Pennant Group, Inc. (PNTG) Investor Outlook: Analyzing a 17.3% Potential Upside Amid Robust Revenue Growth

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector with its impressive growth trajectory and optimistic analyst outlook. As a participant in the Medical Care Facilities..

Wave Life Sciences Ltd. (WVE) Investor Outlook: Analyzing a 163% Potential Upside in Biotechnology

Wave Life Sciences Ltd. (NASDAQ: WVE) is capturing the attention of investors with its compelling potential upside of 163.21%, as outlined by analyst ratings. Operating within the innovative and fast-evolving..

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Gem with an 87.5% Potential Upside

MiMedx Group, Inc. (MDXG), a key player in the biotechnology sector, has captured investor attention with its innovative approach to healthcare solutions. Specializing in the development and distribution of placental..

Evolent Health, Inc (EVH) Stock Analysis: Uncovering a Potential 204.66% Upside

Evolent Health, Inc. (NYSE: EVH) stands at a pivotal moment, capturing the attention of investors with the prospect of a remarkable 204.66% upside, according to analyst ratings. Positioned within the..

Mineralys Therapeutics, Inc. (MLYS): An 85.82% Potential Upside Sparks Investor Interest

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the healthcare sector, specifically within the biotechnology industry, as it continues its pursuit of innovative treatments for conditions driven by dysregulated..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, continues to capture the attention of investors eager to explore opportunities within the healthcare sector. Specializing in therapies for autoimmune diseases,..

Biohaven Ltd. (BHVN) Stock Analysis: A Biotech Challenger with an 84% Potential Upside

Biohaven Ltd. (NASDAQ: BHVN), a prominent player in the biotechnology sector, continues to pique investor interest with its robust pipeline and strategic partnerships. With a market capitalization of $1.51 billion,..

Janux Therapeutics, Inc. (JANX) Investor Outlook: A Potential 383.93% Upside in the Biotech Sector

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning name in the biotechnology industry, has captured investor attention with its cutting-edge immunotherapy platforms and a notably high potential upside of 383.93%. As..

Harrow, Inc. (HROW) Stock Analysis: A 48% Potential Upside in the Eye-Care Pharma Sector

Harrow, Inc. (NASDAQ: HROW), a prominent player in the healthcare sector, specializes in the development of ophthalmic pharmaceutical products. Headquartered in Nashville, Tennessee, this company has carved out a niche..

SS Innovations International (SSII) Stock Analysis: Exploring a Potential Growth Story in Surgical Robotics

SS Innovations International Inc. (SSII), a prominent player in the healthcare sector specializing in medical devices, is making waves in the surgical robotics industry. With a market capitalization of $837.68..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring 53.4% Revenue Growth and a 7.73% Upside Potential

Kestra Medical Technologies, Ltd. (KMTS), a notable player in the healthcare sector, is making waves in the medical instruments and supplies industry. Focused on enhancing cardiovascular patient outcomes through innovative..

LeMaitre Vascular, Inc. (LMAT) Investor Outlook: Exploring an 18% Potential Upside in the Medical Devices Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical instruments and supplies industry. Based in Burlington, Massachusetts, LeMaitre Vascular..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: 13.48% Potential Upside Attracts Investors

Healthcare Services Group, Inc. (NASDAQ: HCSG) is drawing attention from investors with its intriguing potential upside of 13.48%, as analysts set an average target price of $24.50. Operating within the..

Progyny, Inc. (PGNY) Stock Analysis: Discovering a 49.39% Potential Upside in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY) has been making waves in the healthcare sector, particularly within the niche of fertility and women’s health benefits solutions. With a market capitalization of $1.78 billion,..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A 50.75% Upside Potential in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has garnered attention in the biotech sector, particularly for individual investors seeking high-growth opportunities. With a market capitalization of $2.66 billion, Viridian stands out as..

Acadia Healthcare (ACHC) Stock Analysis: Exploring the 13.72% Potential Upside

Acadia Healthcare Company, Inc. (ACHC), a key player in the healthcare sector, specializes in providing essential behavioral healthcare services across the United States and Puerto Rico. With its expansive reach,..

Dynavax Technologies (DVAX) Stock Analysis: Exploring the 3.23% Upside Potential in the Burgeoning Vaccine Market

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the biopharmaceutical sector, is making waves with its focus on developing and commercializing innovative vaccines. With a market capitalization of $1.82..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 188% Potential Upside with Strong Buy Ratings

For investors with an eye on biotech, Ocular Therapeutix, Inc. (NASDAQ: OCUL) presents an intriguing opportunity. Specializing in innovative therapies for retinal diseases and other eye conditions, this Massachusetts-based company..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Strong Revenue Growth and Potential Upside in Medical Devices

Establishment Labs Holdings Inc (NASDAQ: ESTA) is making waves in the healthcare sector, specifically within the medical devices industry. Known for its innovative approach to aesthetic and reconstructive plastic surgery,..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Play with 57.77% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT) is attracting considerable attention in the investment community, particularly among those with an eye for high-reward opportunities in the biotechnology sector. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds